https://www.marketscreener.com/quote/stock/C4-THERAPEUTICS-INC-113170543/news/C4-Therapeutics-CFT8919-Pre-clinical-Data-on-EGFR-L858R-driven-NSCLC-to-be-Presented-at-Keystone-S-33360649/?utm_source=telegram&utm_medium=social&utm_campaign=share